{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:11:40Z","timestamp":1761621100856,"version":"3.40.3"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1999,10,22]]},"DOI":"10.1212\/wnl.53.7.1518","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:42:12Z","timestamp":1336916532000},"page":"1518-1518","source":"Crossref","is-referenced-by-count":42,"title":["The effect of vigabatrin (\u03b3-vinyl GABA) on cerebral blood flow and metabolism"],"prefix":"10.1212","volume":"53","author":[{"given":"M.V.","family":"Spanaki","sequence":"first","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Siegel","sequence":"additional","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kopylev","sequence":"additional","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fazilat","sequence":"additional","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dean","sequence":"additional","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Liow","sequence":"additional","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ben-Menachem","sequence":"additional","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.D.","family":"Gaillard","sequence":"additional","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H.","family":"Theodore","sequence":"additional","affiliation":[{"name":"From the Clinical Epilepsy Section (Drs. Spanaki and SiegelS. Fazilat, and Drs. Dean, Liow, Gaillard, and Theodore), Epilepsy Research Branch, and the Biometry and Field Studies Branch (Dr. Kopylev), NIH\/NINDS, Bethesda, MD; Department of Clinical Neuroscience (Dr. Ben-Menachem), University of Goteborg, Sweden; and Children\u2019s National Medical Center (Dr. Gaillard), Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(81)91179-3"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(82)90042-7"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.9.1.12"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.1.60"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1988.tb05097.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.80.2.165"},{"key":"e_1_3_2_8_2","first-page":"91","volume":"74","year":"1971","unstructured":"Woodbury DM, Kemp JM. Pharmacology and mechanisms of action of diphenylhydantoin. Psychiatr Neurol Neurochir 1971;74:91\u2013117.","journal-title":"Psychiatr Neurol Neurochir"},{"key":"e_1_3_2_9_2","first-page":"727","volume":"228","year":"1986","unstructured":"McLean MJ, MacDonald RL. Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 1986;228:727\u2013738.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1986.54"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410250519"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1982.tb05439.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1987.tb05776.x"},{"key":"e_1_3_2_14_2","first-page":"1363","volume":"30","year":"1981","unstructured":"Loscher W. Valproate-induced changes in GABA metabolism at the subcellular level. Biochem Pharmacol 1981;30:1363\u20131366.","journal-title":"Biochem Pharmacol"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)24966-7","volume":"237","year":"1986","unstructured":"McLean MJ, MacDonald RL. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high-frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 1986;237:1001\u20131011.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00602.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1977.tb10721.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(88)90025-3"},{"key":"e_1_3_2_19_2","first-page":"19","volume":"82","year":"1980","unstructured":"Pericic D. Effects of \u03b3-vinyl GABA on the enzymes of GABA system in specific brain regions. Period Biol 1980;82:19\u201323.","journal-title":"Period Biol"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.12.1051"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.29.4.432"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1987.84"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb07937.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.02-07-00853.1982"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1988.66"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(73)90383-3"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1979.tb11104.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0031-6997(25)00046-8","volume":"42","year":"1990","unstructured":"Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990;42:223\u2013286.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_2_29_2","first-page":"1007","volume":"24","year":"1985","unstructured":"Loscher W. Development of tolerance to the anticonvulsant effect of GABAmimetic drugs in genetically epilepsy-prone gerbils. Pharmacol Biochem Behav 1985;24:1007\u20131013.","journal-title":"Pharmacol Biochem Behav"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03466.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(83)90544-X"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1567"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(97)01147-8"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1980.tb11250.x"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90682-3"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1984.04050230026012"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1994.00540140045013"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.124.5.440"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.8.1494"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb02295.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.12.2501"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.53.7.1518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T22:48:11Z","timestamp":1743115691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.53.7.1518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,22]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,10,22]]}},"alternative-id":["10.1212\/WNL.53.7.1518"],"URL":"https:\/\/doi.org\/10.1212\/wnl.53.7.1518","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"type":"print","value":"0028-3878"},{"type":"electronic","value":"1526-632X"}],"subject":[],"published":{"date-parts":[[1999,10,22]]}}}